2010
DOI: 10.3201/eid1611.100568
|View full text |Cite
|
Sign up to set email alerts
|

Vibrio choleraeO1 Variant with Reduced Susceptibility to Ciprofloxacin, Western Africa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

10
59
1
2

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 60 publications
(72 citation statements)
references
References 8 publications
10
59
1
2
Order By: Relevance
“…Results from the present study confirm the emergence of genotype 7 in Dhaka, and 2008-2010 was the time of transition from ctxB genotype 1 to genotype 7. V. cholerae O1 ET possessing ctxB genotype 7 and showing reduced susceptibility to CIP, as reported in India (Kumar et al, 2009), has been reported recently in western Africa (Quilici et al, 2010). V. cholerae strains with ctxB genotype 7 in Dhaka were uniformly sensitive to CIP; however, switching from ctxB genotype 1 to genotype 7 may be yet another major turning point, especially if the altered ET with the same ctxB genotype 7 was responsible for the severe cholera epidemic that continues in Haiti (Chin et al, 2011).…”
Section: Discussionmentioning
confidence: 53%
See 1 more Smart Citation
“…Results from the present study confirm the emergence of genotype 7 in Dhaka, and 2008-2010 was the time of transition from ctxB genotype 1 to genotype 7. V. cholerae O1 ET possessing ctxB genotype 7 and showing reduced susceptibility to CIP, as reported in India (Kumar et al, 2009), has been reported recently in western Africa (Quilici et al, 2010). V. cholerae strains with ctxB genotype 7 in Dhaka were uniformly sensitive to CIP; however, switching from ctxB genotype 1 to genotype 7 may be yet another major turning point, especially if the altered ET with the same ctxB genotype 7 was responsible for the severe cholera epidemic that continues in Haiti (Chin et al, 2011).…”
Section: Discussionmentioning
confidence: 53%
“…During the past two decades, several cholera-endemic countries including India and Bangladesh have reported V. cholerae serogroup O1 resistance to tetracycline (TE), ampicillin (AMP), kanamycin (KN), sulfonamides, streptomycin (SM), trimethoprim/sulfamethoxazole (SXT), norfloxacin (NOR), gentamicin (CN), furazolidone (FR), ciprofloxacin (CIP) and erythromycin (E) (Faruque et al, 2007;Sack et al, 2004;Jain et al, 2011). The increasing trend of multidrug resistance of V. cholerae associated with severe disease is becoming a serious public health concern globally (Jain et al, 2011;Kumar et al, 2010;Quilici et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Cholera is endemic and a major public health concern in Thailand (Bureau of Epidemiology, 2010), especially for lower socio-economic groups in the north-east region (Tangkanakul & Hanpanjakit, 2007 Jain et al, 2011;Kumar et al, 2010a;Quilici et al, 2010). A recent study reported limited phenotypic, genotypic and virulence characteristics of V. cholerae O1 strains associated with endemic cholera in Thailand (Na-Ubol et al, 2011;Okada et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…At the beginning of 2010, outbreaks of cholera were reported in 15 provinces, including Khon Kaen, the largest provincial city in northeast Thailand. Although treatment for cholera includes a 3 day course of effective antibiotics and rehydration therapy, a progressive increase in drug resistance makes cholera treatment very difficult, not only in Thailand but worldwide (Ang et al, 2010;Jain et al, 2011;Kumar et al, 2010a;Quilici et al, 2010). A recent study reported limited phenotypic, genotypic and virulence characteristics of V. cholerae O1 strains associated with endemic cholera in Thailand (Na-Ubol et al, 2011;Okada et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation